Eun Kyung Kim, Eunyoung Lee, Ji Eun Park, Jae Seung Lee, Hye Sook Choi, Bumhee Park, Seung Soo Sheen, Kwang Joo Park, Chin Kook Rhee, Sang Yeub Lee, Kwang Ha Yoo, Joo Hun Park
BACKGROUND: COPD coexists with many concurrent comorbidities. Cardiovascular complications are deemed to be major causes of death in COPD. Although inhaler therapy is the main therapeutic intervention in COPD, cardiovascular events accompanying inhaler therapy require further investigation. Therefore, this study aimed to investigate new development of cardiovascular events according to each inhaler therapy and comorbidities. METHODS: This study analyzed COPD patients (age ≥ 40 years, N = 199,772) from the Health Insurance Review and Assessment Service (HIRA) database in Korea...
2024: International Journal of Chronic Obstructive Pulmonary Disease